| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 2.94e-11 | 4 | 48 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 2.94e-11 | 4 | 48 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 1.47e-10 | 5 | 48 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 1.02e-09 | 7 | 48 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 3.67e-09 | 9 | 48 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 6.11e-09 | 10 | 48 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 2.07e-08 | 13 | 48 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 2.06e-07 | 55 | 48 | 5 | GO:0008146 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 9.22e-07 | 74 | 48 | 5 | GO:0016782 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.28e-03 | 231 | 48 | 4 | GO:0005085 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 1.40e-10 | 5 | 49 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 3.71e-10 | 17 | 49 | 5 | GO:0034035 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 3.71e-10 | 17 | 49 | 5 | GO:0050427 | |
| GeneOntologyBiologicalProcess | sulfation | 4.76e-09 | 27 | 49 | 5 | GO:0051923 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 6.54e-08 | 17 | 49 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 8.39e-08 | 18 | 49 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.41e-07 | 23 | 49 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 3.54e-06 | 13 | 49 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 4.65e-06 | 47 | 49 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 7.00e-06 | 52 | 49 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 2.15e-05 | 142 | 49 | 5 | GO:0034032 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 2.15e-05 | 142 | 49 | 5 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 2.15e-05 | 142 | 49 | 5 | GO:0033875 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.71e-05 | 73 | 49 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 2.86e-05 | 74 | 49 | 4 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 2.86e-05 | 74 | 49 | 4 | GO:0006584 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.17e-04 | 106 | 49 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 1.95e-04 | 121 | 49 | 4 | GO:0006576 | |
| GeneOntologyBiologicalProcess | dopamine catabolic process | 2.46e-04 | 10 | 49 | 2 | GO:0042420 | |
| GeneOntologyBiologicalProcess | catecholamine catabolic process | 3.00e-04 | 11 | 49 | 2 | GO:0042424 | |
| GeneOntologyBiologicalProcess | catechol-containing compound catabolic process | 3.00e-04 | 11 | 49 | 2 | GO:0019614 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 3.49e-04 | 141 | 49 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 3.59e-04 | 142 | 49 | 4 | GO:0018958 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 4.20e-04 | 148 | 49 | 4 | GO:0009308 | |
| GeneOntologyBiologicalProcess | phenol-containing compound catabolic process | 4.94e-04 | 14 | 49 | 2 | GO:0019336 | |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 5.63e-04 | 160 | 49 | 4 | GO:0051384 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 9.69e-04 | 185 | 49 | 4 | GO:0031960 | |
| GeneOntologyBiologicalProcess | biogenic amine catabolic process | 1.02e-03 | 20 | 49 | 2 | GO:0042402 | |
| MousePheno | abnormal gallbladder size | 1.20e-08 | 32 | 34 | 5 | MP:0020134 | |
| MousePheno | abnormal gallbladder morphology | 3.11e-07 | 60 | 34 | 5 | MP:0005084 | |
| MousePheno | enlarged gallbladder | 5.73e-07 | 28 | 34 | 4 | MP:0009342 | |
| MousePheno | abnormal biliary tract morphology | 8.64e-06 | 117 | 34 | 5 | MP:0005083 | |
| MousePheno | abnormal liver physiology | 4.17e-05 | 401 | 34 | 7 | MP:0000609 | |
| MousePheno | abnormal hepatobiliary system physiology | 6.79e-05 | 433 | 34 | 7 | MP:0002139 | |
| MousePheno | cholestasis | 2.05e-04 | 9 | 34 | 2 | MP:0000610 | |
| Domain | Sulfotransferase_dom | 3.21e-08 | 36 | 48 | 5 | IPR000863 | |
| Domain | Sulfotransfer_1 | 3.21e-08 | 36 | 48 | 5 | PF00685 | |
| Domain | Pentatricopeptide_repeat | 1.58e-03 | 23 | 48 | 2 | IPR002885 | |
| Domain | ARM-type_fold | 1.73e-03 | 339 | 48 | 5 | IPR016024 | |
| Domain | - | 6.77e-03 | 48 | 48 | 2 | 2.120.10.80 | |
| Domain | HEAT | 6.77e-03 | 48 | 48 | 2 | PF02985 | |
| Domain | p53-like_TF_DNA-bd | 8.20e-03 | 53 | 48 | 2 | IPR008967 | |
| Domain | Kelch-typ_b-propeller | 8.81e-03 | 55 | 48 | 2 | IPR015915 | |
| Domain | HEAT | 9.76e-03 | 58 | 48 | 2 | IPR000357 | |
| Domain | Kelch | 9.76e-03 | 58 | 48 | 2 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 1.01e-02 | 59 | 48 | 2 | IPR011043 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 2.50e-10 | 5 | 39 | 4 | M47807 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 4.03e-09 | 23 | 39 | 5 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 5.08e-09 | 24 | 39 | 5 | M16289 | |
| Pathway | KEGG_SULFUR_METABOLISM | 3.51e-08 | 13 | 39 | 4 | M18256 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.53e-07 | 22 | 39 | 4 | MM15888 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.84e-06 | 39 | 39 | 4 | MM15695 | |
| Pathway | WP_RETINOL_METABOLISM | 6.27e-06 | 44 | 39 | 4 | MM15851 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.08e-05 | 107 | 39 | 5 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.18e-05 | 109 | 39 | 5 | M18788 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 1.30e-05 | 17 | 39 | 3 | M39483 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.81e-05 | 29 | 39 | 3 | M45015 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 1.11e-04 | 6 | 39 | 2 | M39437 | |
| Pathway | REACTOME_DRUG_ADME | 3.16e-04 | 119 | 39 | 4 | MM15692 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.24e-04 | 219 | 39 | 5 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.31e-04 | 220 | 39 | 5 | M10320 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 8.17e-04 | 153 | 39 | 4 | MM15844 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 24318996 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 8424956 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 33414449 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 8943792 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 8288252 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 4.10e-12 | 4 | 51 | 4 | 12390022 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 25370010 | ||
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 11389699 | ||
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 29908303 | ||
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 24802129 | ||
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 25053625 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 12438748 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 9370299 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 2.86e-10 | 8 | 51 | 4 | 10594240 | |
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 9166597 | ||
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 5.14e-10 | 9 | 51 | 4 | 23207770 | |
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 8468045 | ||
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 19548878 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 5.14e-10 | 9 | 51 | 4 | 9060415 | |
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 9177785 | ||
| Pubmed | 8.55e-10 | 10 | 51 | 4 | 7601475 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 1.34e-09 | 11 | 51 | 4 | 7613026 | |
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 1.34e-09 | 11 | 51 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 1.34e-09 | 11 | 51 | 4 | 9034160 | |
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 10720750 | ||
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 2.01e-09 | 12 | 51 | 4 | 7706460 | |
| Pubmed | 2.90e-09 | 13 | 51 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 2.90e-09 | 13 | 51 | 4 | 17425406 | |
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 2.97e-09 | 3 | 51 | 3 | 8363592 | |
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 9855620 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 8912648 | ||
| Pubmed | 5.53e-09 | 15 | 51 | 4 | 1741163 | ||
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 32152050 | ||
| Pubmed | 1.24e-08 | 18 | 51 | 4 | 20056724 | ||
| Pubmed | 2.41e-08 | 21 | 51 | 4 | 32301970 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 3.54e-07 | 10 | 51 | 3 | 11535246 | |
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 2.11e-06 | 2 | 51 | 2 | 14871892 | |
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 2.11e-06 | 2 | 51 | 2 | 23358261 | |
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 2.11e-06 | 2 | 51 | 2 | 38069221 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11207031 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12761191 | ||
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 2.11e-06 | 2 | 51 | 2 | 20936502 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10543947 | ||
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 2.11e-06 | 2 | 51 | 2 | 7581483 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 29705271 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15752422 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20417180 | ||
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 2.11e-06 | 2 | 51 | 2 | 10762004 | |
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 2.11e-06 | 2 | 51 | 2 | 8117269 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21362573 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9566757 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8093002 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12469224 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31145702 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10617600 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 16133548 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8033246 | ||
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 3.92e-06 | 72 | 51 | 4 | 8075499 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 7695643 | ||
| Pubmed | Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. | 6.32e-06 | 3 | 51 | 2 | 26067475 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18259693 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 7961757 | ||
| Pubmed | In silico mechanistic profiling to probe small molecule binding to sulfotransferases. | 6.32e-06 | 3 | 51 | 2 | 24039991 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26455829 | ||
| Pubmed | The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. | 6.32e-06 | 3 | 51 | 2 | 32572597 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 8661000 | ||
| Pubmed | Activating Hair Follicle Stem Cells via R-spondin2 to Stimulate Hair Growth. | 1.26e-05 | 4 | 51 | 2 | 27109869 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 26169578 | ||
| Pubmed | Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. | 3.15e-05 | 6 | 51 | 2 | 23467088 | |
| Pubmed | A regulatory network controls nephrocan expression and midgut patterning. | 3.15e-05 | 6 | 51 | 2 | 25209250 | |
| Pubmed | Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. | 3.15e-05 | 6 | 51 | 2 | 15358107 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 33990333 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 24136195 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 11836498 | ||
| Pubmed | Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling. | 5.87e-05 | 8 | 51 | 2 | 27989802 | |
| Pubmed | Meteorin regulates mesendoderm development by enhancing nodal expression. | 1.15e-04 | 11 | 51 | 2 | 24558432 | |
| Pubmed | Foxh1 and Foxa2 are not required for formation of the midgut and hindgut definitive endoderm. | 1.15e-04 | 11 | 51 | 2 | 19896480 | |
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 25684205 | ||
| Pubmed | Common variants at five new loci associated with early-onset inflammatory bowel disease. | 1.38e-04 | 12 | 51 | 2 | 19915574 | |
| Pubmed | Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. | 2.19e-04 | 15 | 51 | 2 | 18632753 | |
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 12419832 | ||
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 32730753 | ||
| Pubmed | 2.53e-04 | 606 | 51 | 6 | 36538041 | ||
| Pubmed | 2.83e-04 | 17 | 51 | 2 | 22627279 | ||
| Pubmed | 3.62e-04 | 94 | 51 | 3 | 25201988 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 3.71e-04 | 231 | 51 | 4 | 36597993 | |
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 5.70e-04 | 24 | 51 | 2 | 30190310 | |
| Pubmed | 6.70e-04 | 26 | 51 | 2 | 28193997 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 7.38e-04 | 1353 | 51 | 8 | 29467282 | |
| Pubmed | 8.93e-04 | 30 | 51 | 2 | 20529763 | ||
| Pubmed | 1.43e-03 | 38 | 51 | 2 | 20214802 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.45e-03 | 569 | 51 | 5 | 30639242 | |
| Interaction | SULT1C2 interactions | 1.07e-07 | 19 | 48 | 4 | int:SULT1C2 | |
| Interaction | SULT1A3 interactions | 2.91e-07 | 24 | 48 | 4 | int:SULT1A3 | |
| Interaction | SULT1A4 interactions | 4.53e-06 | 14 | 48 | 3 | int:SULT1A4 | |
| Interaction | SULT1A2 interactions | 1.20e-05 | 19 | 48 | 3 | int:SULT1A2 | |
| Interaction | SULT1A1 interactions | 1.94e-05 | 67 | 48 | 4 | int:SULT1A1 | |
| Interaction | SULT4A1 interactions | 2.48e-05 | 24 | 48 | 3 | int:SULT4A1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 2.63e-04 | 278 | 51 | 4 | chr16p11 | |
| Cytoband | 16p12.1 | 3.57e-04 | 25 | 51 | 2 | 16p12.1 | |
| Cytoband | 13q14.11 | 8.73e-04 | 39 | 51 | 2 | 13q14.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q11 | 3.27e-03 | 76 | 51 | 2 | chr8q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q32 | 5.16e-03 | 96 | 51 | 2 | chr13q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 6.71e-03 | 345 | 51 | 3 | chr11q12 | |
| Cytoband | 1q21.3 | 7.57e-03 | 117 | 51 | 2 | 1q21.3 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.16e-08 | 14 | 35 | 4 | 762 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 1.02e-07 | 24 | 48 | 4 | MM1317 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 7.40e-06 | 68 | 48 | 4 | MM770 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.09e-05 | 75 | 48 | 4 | MM1084 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 1.72e-05 | 84 | 48 | 4 | MM873 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN | 3.27e-05 | 5 | 48 | 2 | M41007 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 4.61e-05 | 108 | 48 | 4 | MM1334 | |
| Coexpression | LE_EGR2_TARGETS_DN | 6.30e-05 | 117 | 48 | 4 | MM1139 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 8.57e-05 | 399 | 48 | 6 | M41172 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 1.10e-04 | 135 | 48 | 4 | MM753 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 1.53e-04 | 147 | 48 | 4 | MM3753 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 1.92e-04 | 156 | 48 | 4 | MM550 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 1.96e-04 | 157 | 48 | 4 | MM1099 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN | 2.14e-04 | 12 | 48 | 2 | M168 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 2.61e-04 | 490 | 48 | 6 | MM1001 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 2.64e-04 | 491 | 48 | 6 | MM455 | |
| ToppCell | droplet-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-06 | 177 | 49 | 5 | a5b54792ef948a1e1de66301a60e051250189f59 | |
| ToppCell | wk_15-18-Endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.56e-06 | 198 | 49 | 5 | dcf453e22dba90c0ae349fa6c3d4c20758bb95af | |
| ToppCell | wk_20-22-Endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.62e-06 | 199 | 49 | 5 | 07be9509a8ec9c9a7d721912d77c20e841f49808 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.57e-05 | 169 | 49 | 4 | b66ffc2b2b6bfcc3a6e639d9d31d3de95f4a94e1 | |
| ToppCell | 11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 3.82e-05 | 172 | 49 | 4 | 9d4d92e2d16dfc8a394f2641653bb97de20a2530 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.18e-05 | 176 | 49 | 4 | eea554ea75580f8dd5fefb57e7f33441ab86b884 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.18e-05 | 176 | 49 | 4 | d5cee483d2a60f82fdc67ad447b589d022fe8c97 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.46e-05 | 179 | 49 | 4 | 040a7e916baaf81f44339dc721ab2afcd2c22388 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-05 | 193 | 49 | 4 | aaf681f16f310168e4719464814a1fc0a2f8431a | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 195 | 49 | 4 | c0ea25ed1a849e6efff885e98013a4f1d5134758 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.22e-05 | 195 | 49 | 4 | fde8e7b38b3631109b95ef111c5f6e3f9878cfbd | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 195 | 49 | 4 | cc3d6f98d310e8840ff497d7258c5ccf54e6c624 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 195 | 49 | 4 | dfc5da514fb34a2c318a5c4c61f44049fa43960e | |
| ToppCell | wk_08-11-Endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.35e-05 | 196 | 49 | 4 | 0e545874083fd8e954a49fc397d57a86b081008b | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.47e-05 | 197 | 49 | 4 | 2ed92f942475db6836e48da3c6b8235eb8691c38 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.47e-05 | 197 | 49 | 4 | 9b3d6fe76dd7d61a286a28d9466b5f2fece048e1 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Late_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.47e-05 | 197 | 49 | 4 | 797ea1c9f75f88b51fdfc17a2b27ed0199ae64c9 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.60e-05 | 198 | 49 | 4 | a75499f8f1630359b64717c300621aa3b1ab44d4 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.60e-05 | 198 | 49 | 4 | 75270600b5b29187dfa86f01f8f927ae0621cda4 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.73e-05 | 199 | 49 | 4 | 70e05d7c0c68c28754ce0e72434b205aed6287ae | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.73e-05 | 199 | 49 | 4 | 243b7c72f83c12a34d8ea300fca63b04216268a4 | |
| Drug | luciferyl sulfate | 7.78e-10 | 7 | 51 | 4 | CID011953812 | |
| Drug | dopamine-4-O-sulfate | 7.78e-10 | 7 | 51 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 7.78e-10 | 7 | 51 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 7.78e-10 | 7 | 51 | 4 | CID003035977 | |
| Drug | 2-iodophenol | 1.55e-09 | 8 | 51 | 4 | CID000010784 | |
| Drug | dopamine 3-O-sulfate | 1.55e-09 | 8 | 51 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 1.55e-09 | 8 | 51 | 4 | CID003037707 | |
| Drug | 1m2q | 2.93e-09 | 26 | 51 | 5 | CID005326637 | |
| Drug | EM-139 | 1.57e-08 | 13 | 51 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 2.20e-08 | 14 | 51 | 4 | CID000020908 | |
| Drug | deoxoestrone | 2.20e-08 | 14 | 51 | 4 | CID000005888 | |
| Drug | arylsulfate | 2.99e-08 | 15 | 51 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 2.99e-08 | 15 | 51 | 4 | CID000002895 | |
| Drug | A-44 | 3.98e-08 | 16 | 51 | 4 | CID000120353 | |
| Drug | NSC674039 | 4.69e-08 | 44 | 51 | 5 | CID000001249 | |
| Drug | benzilic acid | 5.20e-08 | 17 | 51 | 4 | CID000006463 | |
| Drug | AC1Q6OHG | 8.44e-08 | 19 | 51 | 4 | CID000115063 | |
| Drug | pedunculagin | 8.44e-08 | 19 | 51 | 4 | CID000442688 | |
| Drug | PLP-Glu | 1.05e-07 | 20 | 51 | 4 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 1.30e-07 | 21 | 51 | 4 | CID000005895 | |
| Drug | MeA alpha C | 1.59e-07 | 22 | 51 | 4 | CID000062244 | |
| Drug | AABSSN | 1.59e-07 | 22 | 51 | 4 | CID005464134 | |
| Drug | taselin | 1.92e-07 | 23 | 51 | 4 | CID000023846 | |
| Drug | AalphaC | 2.30e-07 | 24 | 51 | 4 | CID000062805 | |
| Drug | minoxidil sulphate | 2.73e-07 | 25 | 51 | 4 | CID000004202 | |
| Drug | 2-pentanone | 2.73e-07 | 25 | 51 | 4 | CID000007895 | |
| Drug | AzMC | 2.73e-07 | 25 | 51 | 4 | CID000064986 | |
| Drug | alpha-methyldopamine | 3.22e-07 | 26 | 51 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 3.22e-07 | 26 | 51 | 4 | CID000115245 | |
| Drug | Phosphoadenosine Phosphosulfate | 3.68e-07 | 7 | 51 | 3 | ctd:D010724 | |
| Drug | Glu-P-2 | 5.09e-07 | 29 | 51 | 4 | CID000049970 | |
| Drug | 3,3'-T2 | 5.86e-07 | 30 | 51 | 4 | CID000065559 | |
| Drug | N-hydroxy-4-aminobiphenyl | 5.88e-07 | 8 | 51 | 3 | ctd:C014593 | |
| Drug | A2'p5'A2'p5'A | 6.72e-07 | 31 | 51 | 4 | CID000122642 | |
| Drug | barium hydroxide | 6.72e-07 | 31 | 51 | 4 | CID000028387 | |
| Drug | acetaminophen sulfate | 6.72e-07 | 31 | 51 | 4 | CID000083939 | |
| Drug | DCNP | 8.71e-07 | 33 | 51 | 4 | CID000012066 | |
| Drug | reverse T3 | 1.10e-06 | 82 | 51 | 5 | CID000022069 | |
| Drug | mefenamic acid | 1.40e-06 | 37 | 51 | 4 | CID000004044 | |
| Drug | phenylhydroxylamine | 1.56e-06 | 38 | 51 | 4 | CID000007518 | |
| Drug | d-equilenin | 2.13e-06 | 41 | 51 | 4 | CID000010597 | |
| Drug | L-alpha-methyldopa | 2.35e-06 | 42 | 51 | 4 | CID000004138 | |
| Drug | Woodward's reagent K | 2.58e-06 | 43 | 51 | 4 | CID000077804 | |
| Drug | adenosine 3'-5'-diphosphate | 2.68e-06 | 98 | 51 | 5 | CID000000073 | |
| Drug | 1IIg | 3.11e-06 | 45 | 51 | 4 | CID000001682 | |
| Drug | NDPS | 3.11e-06 | 45 | 51 | 4 | CID000090363 | |
| Drug | 4-octylphenol | 3.71e-06 | 47 | 51 | 4 | CID000015730 | |
| Drug | A21250 | 3.76e-06 | 105 | 51 | 5 | CID000000990 | |
| Drug | sulfamethazine | 4.04e-06 | 48 | 51 | 4 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 4.04e-06 | 48 | 51 | 4 | CID000005896 | |
| Drug | salicylamide | 4.04e-06 | 48 | 51 | 4 | CID000005147 | |
| Drug | 5-hydroxymethylfurfural | 4.92e-06 | 2 | 51 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 4.92e-06 | 2 | 51 | 2 | ctd:C012365 | |
| Drug | Hydroxytryptophol | 4.92e-06 | 2 | 51 | 2 | ctd:D006917 | |
| Drug | 9-hydroxybenzo(a)pyrene | 6.03e-06 | 53 | 51 | 4 | CID000028598 | |
| Drug | minoxidil | 6.50e-06 | 54 | 51 | 4 | CID000004201 | |
| Drug | androstenediol | 6.50e-06 | 54 | 51 | 4 | CID000010634 | |
| Drug | MeIQx | 7.00e-06 | 55 | 51 | 4 | CID000062275 | |
| Drug | PhIP-HCl | 8.16e-06 | 123 | 51 | 5 | CID000001530 | |
| Drug | NSC36919 | 8.66e-06 | 58 | 51 | 4 | CID000235496 | |
| Drug | 4-hydroxyestrone | 9.28e-06 | 59 | 51 | 4 | CID000018418 | |
| Drug | acetaminophen glucuronide | 9.28e-06 | 59 | 51 | 4 | CID000083944 | |
| Drug | 3-OHBaP | 1.21e-05 | 63 | 51 | 4 | CID000025890 | |
| Drug | 4-nonylphenol | 1.28e-05 | 64 | 51 | 4 | CID000001752 | |
| Drug | epicatechin-3-gallate | 1.37e-05 | 65 | 51 | 4 | CID000065056 | |
| Drug | 5-hydroxyindole | 1.47e-05 | 3 | 51 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 1.47e-05 | 3 | 51 | 2 | ctd:D008914 | |
| Drug | 5-hydroxy-3-methylindole | 1.47e-05 | 3 | 51 | 2 | CID000192734 | |
| Drug | 8-azaadenine | 1.47e-05 | 3 | 51 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 1.47e-05 | 3 | 51 | 2 | ctd:C030629 | |
| Drug | Pyrethroids | 1.94e-05 | 71 | 51 | 4 | CID000005053 | |
| Drug | adenylylsulfate | 2.05e-05 | 72 | 51 | 4 | CID000000228 | |
| Drug | 7-hydroxycoumarin | 2.41e-05 | 75 | 51 | 4 | CID005281426 | |
| Drug | benzyloxyresorufin | 2.82e-05 | 78 | 51 | 4 | CID000114982 | |
| Drug | Chebi:32701 | 2.94e-05 | 4 | 51 | 2 | CID005460855 | |
| Drug | 4-hydroxyestradiol | 2.96e-05 | 79 | 51 | 4 | CID000001743 | |
| Drug | estrone sulfate | 3.18e-05 | 163 | 51 | 5 | CID000000699 | |
| Drug | pinocembrin | 4.90e-05 | 5 | 51 | 2 | ctd:C016063 | |
| Drug | TKPP | 4.90e-05 | 5 | 51 | 2 | CID000023740 | |
| Drug | harmol | 4.90e-05 | 5 | 51 | 2 | ctd:C001326 | |
| Drug | 4-aminobiphenyl | 5.39e-05 | 92 | 51 | 4 | CID000007102 | |
| Drug | p-nitroanisole | 5.39e-05 | 92 | 51 | 4 | CID000007485 | |
| Drug | 2-naphthol | 5.63e-05 | 93 | 51 | 4 | CID000008663 | |
| Drug | 1-naphthol | 6.91e-05 | 98 | 51 | 4 | CID000007005 | |
| Drug | 2-Sulfotrehalose | 7.34e-05 | 6 | 51 | 2 | CID000124677 | |
| Drug | N-hydroxy-2-acetylaminophenanthrene | 7.34e-05 | 6 | 51 | 2 | CID000017102 | |
| Drug | MBED | 7.34e-05 | 6 | 51 | 2 | CID000129958 | |
| Drug | 1 C2 | 7.47e-05 | 100 | 51 | 4 | CID005327152 | |
| Drug | 4-HT | 9.03e-05 | 105 | 51 | 4 | CID005284643 | |
| Drug | AC1L577W | 1.03e-04 | 7 | 51 | 2 | CID000171279 | |
| Drug | N-acetyl-2-naphthylhydroxylamine | 1.03e-04 | 7 | 51 | 2 | CID000017272 | |
| Drug | 2-naphthylamine | 1.08e-04 | 110 | 51 | 4 | CID000007057 | |
| Drug | gallic acid | 1.33e-04 | 116 | 51 | 4 | CID000000370 | |
| Drug | 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine | 1.37e-04 | 8 | 51 | 2 | ctd:C077584 | |
| Drug | pentachlorophenol | 1.51e-04 | 120 | 51 | 4 | CID000000992 | |
| Drug | phenylglyoxal | 1.56e-04 | 121 | 51 | 4 | CID000014090 | |
| Drug | catechol | 1.71e-04 | 48 | 51 | 3 | ctd:C034221 | |
| Drug | 3-hydroxy-3-methyloxindole | 1.75e-04 | 9 | 51 | 2 | CID000151066 | |
| Drug | 8-oxo-dGTP | 1.93e-04 | 50 | 51 | 3 | CID000107902 | |
| Drug | 1-hydroxypyrene | 2.04e-04 | 51 | 51 | 3 | ctd:C033146 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 1.69e-04 | 12 | 48 | 2 | C3160718 | |
| Disease | X-12707 measurement | 1.69e-04 | 12 | 48 | 2 | EFO_0800720 | |
| Disease | ascorbic acid 3-sulfate measurement | 2.33e-04 | 14 | 48 | 2 | EFO_0800173 | |
| Disease | Autosome Abnormalities | 3.06e-04 | 16 | 48 | 2 | C0004403 | |
| Disease | Chromosome Aberrations | 3.06e-04 | 16 | 48 | 2 | C0008625 | |
| Disease | lysophosphatidylcholine 20:4 measurement | 1.25e-03 | 32 | 48 | 2 | EFO_0010363 | |
| Disease | allergic rhinitis | 1.34e-03 | 133 | 48 | 3 | EFO_0005854 | |
| Disease | neutrophil count | 1.61e-03 | 1382 | 48 | 8 | EFO_0004833 | |
| Disease | Moyamoya disease | 1.94e-03 | 40 | 48 | 2 | MONDO_0016820 | |
| Disease | Colonic Neoplasms | 1.96e-03 | 152 | 48 | 3 | C0009375 | |
| Disease | Malignant tumor of colon | 2.22e-03 | 159 | 48 | 3 | C0007102 | |
| Disease | coffee consumption measurement, tea consumption measurement | 2.35e-03 | 44 | 48 | 2 | EFO_0006781, EFO_0010091 | |
| Disease | anthropometric measurement | 2.60e-03 | 168 | 48 | 3 | EFO_0004302 | |
| Disease | ecosanoids measurement | 3.64e-03 | 55 | 48 | 2 | EFO_0020044 | |
| Disease | Nasal Cavity Polyp | 3.64e-03 | 55 | 48 | 2 | EFO_1000391 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 3.91e-03 | 57 | 48 | 2 | EFO_0022284 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YQCVIYQPPKEPHML | 111 | Q9NP99 | |
| FEVYPELMEKYPCAV | 66 | Q8N1L4 | |
| VFLEPHEEMTLCKYY | 46 | P51946 | |
| PLEIKDNHVEYYTMP | 361 | Q8NHY0 | |
| EALAPYQPLAMKCIY | 431 | Q9NV88 | |
| YQPLAMKCIYCPIDT | 436 | Q9NV88 | |
| HIPCLMPEYFEPQIK | 136 | Q96EY7 | |
| EIMPHIYNYLIFDKP | 906 | O00370 | |
| HDKPPYTYLAMIALV | 31 | O75593 | |
| PEKLTHHMPLFYCLY | 536 | P59045 | |
| THAMYACPKLPYNKE | 1101 | Q99700 | |
| PEYAKYLKYPQCLHM | 61 | Q9Y3C7 | |
| AEYCALYEKMVLPPR | 86 | A8MZ36 | |
| YCICDIPVMKVYNPA | 526 | Q8WVZ9 | |
| EINHFYCADPPLIKM | 171 | Q8NGP4 | |
| DCYVAICKPLRYPMI | 121 | Q8NH89 | |
| DENIPLKMHYLPVIY | 26 | Q96P68 | |
| HCFPYVKKRIPVMYQ | 1926 | Q9BZ29 | |
| MINISIGYHYPPICL | 151 | Q69384 | |
| YPELMCEQYVTFIKP | 76 | Q5K131 | |
| ILPEAMVCYLENYEP | 1171 | O75165 | |
| KMPQCHTLLYVYNLP | 506 | Q9Y4F3 | |
| PLPNDVCLTMKLFYY | 166 | Q86X24 | |
| LMVQCFPPHYEIFKN | 296 | O60645 | |
| NVKESYCPLVPHTMY | 356 | Q92902 | |
| PMLLNYIPVCYKILH | 1281 | Q6ZTR5 | |
| YCICDIPVMKVYNPV | 526 | Q86V97 | |
| PELKVIEMPYAYQCC | 466 | O75473 | |
| ICHPLRYPILMKEYA | 126 | Q8NGZ0 | |
| CEYDIPMLPHVQKYL | 246 | Q86X27 | |
| YVSPACKKPLIHMYE | 1191 | Q7Z2Y5 | |
| FHPECPKLYKEYFRM | 171 | Q9NYH9 | |
| YLHFVCKPEMGLPYQ | 366 | Q9H6I2 | |
| PLPYMIQCKHFVTQY | 431 | Q6NUJ1 | |
| YEYLDIKCVPPEMRE | 311 | Q6UW49 | |
| EHPYKPACVMHYKVT | 2026 | O75592 | |
| VPYYDIFMPSLKHIV | 536 | O60518 | |
| YVAICKPLHYPIIMS | 121 | A6NF89 | |
| KPLHYPIIMSSKVCY | 126 | A6NF89 | |
| HPVLYLFYEDMKENP | 186 | P0DMN0 | |
| HPVLYLFYEDMKENP | 186 | P0DMM9 | |
| VYHLEEPKCLEIYPQ | 576 | Q9H6W3 | |
| EKCLPVYYEQLVLHP | 231 | O60704 | |
| MRPNDIVYDCLPLYH | 276 | Q6P1M0 | |
| YAPCYEALLPKEKMR | 806 | Q15413 | |
| HPVLYLFYEDMKENP | 186 | P50225 | |
| HPVLYLFYEDMKENP | 186 | P50226 | |
| MDQLPVHSIKCVPLY | 366 | Q9UKN8 | |
| DRHVMQPYYKDILPC | 781 | P78527 | |
| HMEYECPYLVYVPVV | 311 | Q9NYA1 | |
| MCVYVYLILPLPHYV | 481 | Q8IWB9 | |
| LCKLYNLPQHPDVEM | 156 | Q7Z7E8 | |
| CLLYKYMYIHRPPTQ | 631 | Q8N8K9 | |
| PHYPVLQRDLYMKAE | 196 | Q9Y2G1 |